<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045043"><TermName>DHA-paclitaxel</TermName><TermPronunciation>(...PA-klih-TAK-sil)</TermPronunciation><TermDefinition><DefinitionText>A combination of DHA (a natural fatty acid) and paclitaxel (an anticancer drug) being studied in the treatment of cancer. It is a type of mitotic inhibitor.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000704899" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;DHA-paclitaxel&quot;" language="en" id="_3"/><MediaLink ref="CDR0000704898" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;DHA-paclitaxel&quot;" language="es" id="_4"/><SpanishTermName>DHA-paclitaxel</SpanishTermName><SpanishTermDefinition><DefinitionText>Combinación de DHA (un ácido graso natural) y paclitaxel (un medicamento contra el cáncer) en estudio para el tratamiento de cáncer. Es un tipo de inhibidor mitótico.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2007-07-06</DateLastModified></GlossaryTerm>
